Terms: = Sarcomas AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Treatment
26 results:
1. 3D-Printed Magnesium Peroxide-Incorporated Scaffolds with Sustained Oxygen Release and Enhanced Photothermal Performance for Osteosarcoma Multimodal treatments.
Haixia X; Peng Z; Jiezhao L; Huiling G; Xie C; Yihan W; Yanglei J; Li J; Wang C; Wenning X; Lixin Z; Liu C
ACS Appl Mater Interfaces; 2024 Feb; 16(8):9626-9639. PubMed ID: 38372238
[TBL] [Abstract] [Full Text] [Related]
2. Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.
Tan Q; Gao R; Zhang X; Yang J; Xing P; Yang S; Wang D; Wang G; Wang S; Yao J; Zhang Z; Tang L; Yu X; Han X; Shi Y
Cancer Immunol Immunother; 2024 Feb; 73(3):47. PubMed ID: 38349411
[TBL] [Abstract] [Full Text] [Related]
3. A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration.
Gong M; Huang Y; Feng H; Lin J; Huang A; Hu J; Tang Q; Zhu X; Han S; Lu J; Wang J
J Control Release; 2023 Mar; 355():68-84. PubMed ID: 36682726
[TBL] [Abstract] [Full Text] [Related]
4. Doxorubicin-Loaded Polymeric Meshes Prevent Local Recurrence after Sarcoma Resection While Avoiding Cardiotoxicity.
Bressler EM; Chu NQ; Sabatelle RC; Mahvi DA; Korunes-Miller JT; Nagashima F; Ichinose F; Liu R; Grinstaff MW; Colson YL; Raut CP
Cancer Res; 2022 Dec; 82(23):4474-4484. PubMed ID: 36169924
[TBL] [Abstract] [Full Text] [Related]
5. 3D-printing magnesium-polycaprolactone loaded with melatonin inhibits the development of osteosarcoma by regulating cell-in-cell structures.
Zhang W; Zhao W; Li Q; Zhao D; Qu J; Yuan Z; Cheng Z; Zhu X; Zhuang X; Zhang Z
J Nanobiotechnology; 2021 Sep; 19(1):263. PubMed ID: 34481503
[TBL] [Abstract] [Full Text] [Related]
6. VEGF-C/VEGFR-3/iNOS Signaling in Osteosarcoma MG63 Cells Mediates Stimulatory Effects on Human Umbilical Vein Endothelial Cell Proliferation.
Lv J; Yuan J; Xu CJ; Hao JQ; Qin YC; Wang XQ; Wang YF
Chin Med Sci J; 2021 Mar; 36(1):35-42. PubMed ID: 33853707
[TBL] [Abstract] [Full Text] [Related]
7. Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers.
Prasad SR; Jayakrishnan A; Kumar TSS
J Mater Sci Mater Med; 2020 May; 31(5):44. PubMed ID: 32367204
[TBL] [Abstract] [Full Text] [Related]
8. Primary Lymphoma of the Heart: A Case Report of Surgical treatment and Review of the Literature.
Liu S; Ren C; Wang Y
Heart Surg Forum; 2019 May; 22(3):E225-E228. PubMed ID: 31237548
[TBL] [Abstract] [Full Text] [Related]
9. Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database.
Kim YA; Cho H; Lee N; Jung SY; Sim SH; Park IH; Lee S; Lee ES; Kim HJ
Cancer Med; 2018 Dec; 7(12):6084-6092. PubMed ID: 30453386
[TBL] [Abstract] [Full Text] [Related]
10. Oroxylin A inhibits Kaposi's sarcoma-associated herpes virus (KSHV) vIL-6-mediated lymphatic reprogramming of vascular endothelial cells through modulating PPARγ/Prox1 axis.
Zhu X; Chen Y; Zhu W; Ji M; Xu J; Guo Y; Gao F; Gu W; Yang X; Zhang C
J Med Virol; 2019 Mar; 91(3):463-472. PubMed ID: 30318784
[TBL] [Abstract] [Full Text] [Related]
11. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
Ferrari SM; Bocci G; Di Desidero T; Elia G; Ruffilli I; Ragusa F; Orlandi P; Paparo SR; Patrizio A; Piaggi S; La Motta C; Ulisse S; Baldini E; Materazzi G; Miccoli P; Antonelli A; Fallahi P
Oncol Rep; 2018 May; 39(5):2225-2234. PubMed ID: 29517103
[TBL] [Abstract] [Full Text] [Related]
12. Therapeutic pcl scaffold for reparation of resected osteosarcoma defect.
Palamà IE; Arcadio V; D'Amone S; Biasiucci M; Gigli G; Cortese B
Sci Rep; 2017 Oct; 7(1):12672. PubMed ID: 28978922
[TBL] [Abstract] [Full Text] [Related]
13. FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen.
Barone A; Chi DC; Theoret MR; Chen H; He K; Kufrin D; Helms WS; Subramaniam S; Zhao H; Patel A; Goldberg KB; Keegan P; Pazdur R
Clin Cancer Res; 2017 Dec; 23(24):7448-7453. PubMed ID: 28774898
[TBL] [Abstract] [Full Text] [Related]
14. Antitumor Response of VEGFR2- and vegfr3-Amplified Angiosarcoma to Pazopanib.
Ravi V; Sanford EM; Wang WL; Ross JS; Ramesh N; Futreal A; Patel S; Stephens PJ; Miller VA; Ali SM
J Natl Compr Canc Netw; 2016 May; 14(5):499-502. PubMed ID: 27160228
[TBL] [Abstract] [Full Text] [Related]
15. A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment.
Cabanillas ME; Schlumberger M; Jarzab B; Martins RG; Pacini F; Robinson B; McCaffrey JC; Shah MH; Bodenner DL; Topliss D; Andresen C; O'Brien JP; Ren M; Funahashi Y; Allison R; Elisei R; Newbold K; Licitra LF; Sherman SI; Ball DW
Cancer; 2015 Aug; 121(16):2749-56. PubMed ID: 25913680
[TBL] [Abstract] [Full Text] [Related]
16. The utility of MYC and flt4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast.
Cornejo KM; Deng A; Wu H; Cosar EF; Khan A; St Cyr M; Tomaszewicz K; Dresser K; O'Donnell P; Hutchinson L
Hum Pathol; 2015 Jun; 46(6):868-75. PubMed ID: 25864386
[TBL] [Abstract] [Full Text] [Related]
17. Lymphangiosarcoma of the scalp.
Mamelak AJ; Collie MR; Kroll R; Hanson ML; Harris HM
J Cutan Med Surg; 2014; 18(2):132-6. PubMed ID: 24636440
[TBL] [Abstract] [Full Text] [Related]
18. Angiosarcomas and other sarcomas of endothelial origin.
Cioffi A; Reichert S; Antonescu CR; Maki RG
Hematol Oncol Clin North Am; 2013 Oct; 27(5):975-88. PubMed ID: 24093171
[TBL] [Abstract] [Full Text] [Related]
19. Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
Kilvaer TK; Valkov A; Sorbye S; Smeland E; Bremnes RM; Busund LT; Donnem T
PLoS One; 2010 Dec; 5(12):e15368. PubMed ID: 21179485
[TBL] [Abstract] [Full Text] [Related]
20. Cutaneous angiosarcoma: own experience over 13 years. Clinical features, disease course and immunohistochemical profile.
Donghi D; Kerl K; Dummer R; Schoenewolf N; Cozzio A
J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1230-4. PubMed ID: 20236193
[TBL] [Abstract] [Full Text] [Related]
[Next]
